Sponsored Ad
Search Results

(±)-N-3-Benzylnirvanol 50 mg  | 97.16%

TargetMol

(±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-) -n-3-Benzylnirvanoll. (+) -n-3-Benzylnirvanol and (-) -n-3-Benzylnirvanoll are selective inhibitors of cytochrome P450 that inhibit CYP2C19, and (±) -n-3-benzylnonanol reduces plasma cholesterol levels in mice.

More Information Supplier Page

(±)-N-3-Benzylnirvanol 100 mg  | 97.16%

TargetMol

(±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-) -n-3-Benzylnirvanoll. (+) -n-3-Benzylnirvanol and (-) -n-3-Benzylnirvanoll are selective inhibitors of cytochrome P450 that inhibit CYP2C19, and (±) -n-3-benzylnonanol reduces plasma cholesterol levels in mice.

More Information Supplier Page

(±)-N-3-Benzylnirvanol 500 mg  | 97.16%

TargetMol

(±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-) -n-3-Benzylnirvanoll. (+) -n-3-Benzylnirvanol and (-) -n-3-Benzylnirvanoll are selective inhibitors of cytochrome P450 that inhibit CYP2C19, and (±) -n-3-benzylnonanol reduces plasma cholesterol levels in mice.

More Information Supplier Page

(±)-N-3-Benzylnirvanol Please inquire  | ≥98%

BOC Sciences

(±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-benzylnirvanol and (-)-N-3-benzylnirvanol. (+)-N-3-benzylnirvanol and (-)-N-3-benzylnirvanol are inhibitors of the cytochrome P450 (CYP) isoform CYP2C19 (Kis = 0.292 and 5.3 μM, respectively).

More Information Supplier Page